2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders

Details for Australian Patent Application No. 2004249494 (hide)

Owner AstraZeneca AB

Inventors Lindstedt-Alstermark, Eva-Lotte

Agent Davies Collison Cave

Pub. Number AU-B-2004249494

PCT Pub. Number WO2004/113276

Priority 0314078.7 18.06.03 GB

Filing date 16 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 20 March 2008

International Classifications

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07C 309/66 (2006.01) Sulfonic acids

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/113276 Priority application(s): WO2004/113276

20 March 2008 Application Accepted

  Published as AU-B-2004249494

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249495-Thienopyridone derivatives as kinase inhibitors

2004249493-Method and apparatus for the application of powder material to substrates